About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 49 record(s)
Req # A-2023-00020
Briefing Note: CEO Quarterly Meeting with Ontario Energy Board (OEB) – 5 October 2023, REFERENCE NUMBER: 1478263Organization: Canada Energy Regulator
February 2024
Req # A-2023-037
Provide all records of business value (emails, policies, directions, advice, etc.) concerning Air Canada and section 91 of the Official Languages Act. For example, include information received in relation to reporting requirements or other information provided by Air Canada to OCOL concerning compliance with OLA 91. Do not process records in relation to individual complaints unless the data can be aggregated and anonymized. Date range: January 2020 to present.Organization: Office of the Commissioner of Official Languages
February 2024
Req # A-2024-002
"I would like to receive a complete organization plan (organization charts) for the entire Office of the Commissioner of Official Languages, including regional and satellite offices."Organization: Office of the Commissioner of Official Languages
February 2024
Req # A-2024-54596
Submission of the Public Health Agency of Canada (PHAC) to the Patented Medicine Prices Review Board’s November 2023 consultation on the Scoping paper of the Board's Guidelines. Submissions from other stakeholders can be viewed here: https://www.canada.ca/en/patented-medicine-prices-review/services/consultations/scoping-paper-board-guidelines.htmlOrganization: Patented Medicine Prices Review Board Canada
February 2024
Nothing to report this month
Organization: Canada Deposit Insurance Corporation
Nothing to report this month
Organization: Canada-Newfoundland and Labrador Offshore Petroleum Board
Req # A-2022-00010
I'm seeking a copy of the following briefing note: Title: CER Input to NRCan for Clerk of the Privy Council (Clerk) and Deputy Ministers trip to Edmonton, 11-13 January 2023. Reference # 1442658Organization: Canada Energy Regulator
February 2023
Req # A-2022-036
“All emails sent and received by Martin Labelle in January and February 2023."Organization: Office of the Commissioner of Official Languages
February 2023
Req # A-2023-02395
Copies of all correspondence and communications between the (then) acting chairperson of the Patented Medicines Prices Review Board Mélanie Bourassa-Forcier and Innovative Medicines Canada (IMC) between October 1, 2022 and December 5, 2022 regarding the PMPRB's new draft guidelines and the consultation process. Please include all responses to Innovative Medicines Canada (IMC)'s communications/correspondence from the (then) acting chairperson of the Patented Medicines Prices Review Board Mélanie Bourassa-Forcier.Organization: Patented Medicine Prices Review Board Canada
February 2023
Req # A-2022-09063
Copies of any emails sent by the Vice-chair regarding any of the following topics: (i) her resignation or intent to resign or the reasons for her resignation. (ii) the draft guidelines. (iii) the consultation process for the draft guidelines. (iv) the impact of the Merck Canada, IMC, and/or Alexion court decisions on the PMPRB, including its draft guidelines. From November 1, 2022 to December 5, 2022.Organization: Patented Medicine Prices Review Board Canada
February 2023